Skip to main content
. 2015 Mar 20;10(3):e0119526. doi: 10.1371/journal.pone.0119526

Fig 5. Homing receptor expression by Type 2 CD56bright NK cells.

Fig 5

In (A) the percentage of Type 2 CD56bright NK cells expressing ITGA4 in control patients was significantly increased in the 2nd trimester versus 1st and 3rd trimesters (*P<0.05). No significant differences were detected in T1DM patients. In (B) Log of and (C-D) percentage of Type 2 CD56bright NK cells expressing SELL (B), CXCR3 (C) and CXCR4 (D) are shown. A significant increase in Type 2 CD56bright NK cells expressing SELL (B), CXCR3 (C) and CXCR4 (D) was detected in 2nd compared to 1st trimester (*P<0.05; **P<0.01). Type 2 CD56bright NK cells expressing CXCR3 were also significantly higher in 2nd trimester than postpartum (*P<0.05). Control patients had more Type 2 CD56bright NK cells expressing SELL (B), CXCR3 (C) and CXCR4 (D) than T1DM patients in 2nd trimester (#P<0.05).